Pattern Bioscience has filed a notice of an exempt offering of securities to raise $28,700,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Pattern Bioscience is raising $28,700,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Nicolas Arab played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Pattern Bioscience
Our mission is simple: We will improve the world’s most important health decisions. Whether you call them superbugs, pan-resistant organisms, or just plain deadly, drug-resistant microbes have become a global public health crisis. Pattern is a clinical diagnostics company dedicated to bringing experience, innovation and technology to the fight against antibiotic resistance.
To learn more about Pattern Bioscience, visit http://www.pattern.bio/
Contact:
Nicolas Arab, Chief Executive Officer
512-784-8706
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.